Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kyntra Bio (KYNB) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Kyntra Bio (KYNB) over the last 12 years, with Q3 2025 value amounting to $9000.0.

  • Kyntra Bio's Capital Expenditures fell 8902.44% to $9000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $179000.0, marking a year-over-year decrease of 5239.36%. This contributed to the annual value of $266000.0 for FY2024, which is 8944.03% down from last year.
  • According to the latest figures from Q3 2025, Kyntra Bio's Capital Expenditures is $9000.0, which was down 8902.44% from $13000.0 recorded in Q2 2025.
  • Kyntra Bio's 5-year Capital Expenditures high stood at $1.7 million for Q2 2021, and its period low was $9000.0 during Q3 2025.
  • In the last 5 years, Kyntra Bio's Capital Expenditures had a median value of $518000.0 in 2021 and averaged $618421.1.
  • Per our database at Business Quant, Kyntra Bio's Capital Expenditures surged by 27589.5% in 2021 and then crashed by 9859.01% in 2024.
  • Quarter analysis of 5 years shows Kyntra Bio's Capital Expenditures stood at $1.4 million in 2021, then crashed by 76.15% to $333000.0 in 2022, then decreased by 24.62% to $251000.0 in 2023, then tumbled by 43.82% to $141000.0 in 2024, then tumbled by 93.62% to $9000.0 in 2025.
  • Its last three reported values are $9000.0 in Q3 2025, $13000.0 for Q2 2025, and $16000.0 during Q1 2025.